Overactive and underactive bladder dysfunction is reflected by alterations in urothelial ATP and NO release

被引:60
|
作者
Munoz, Alvaro [1 ]
Smith, Christopher P. [1 ,3 ]
Boone, Timothy B. [1 ,2 ]
Somogyi, George T. [1 ]
机构
[1] Baylor Coll Med, Scott Dept Urol, Lab Neurourol, Houston, TX 77030 USA
[2] Methodist Hosp, Dept Urol, Houston, TX 77030 USA
[3] Michael E Debakey VA Med Ctr, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Diabetes; Urinary bladder; Urothelium; ATP release; NO release; BOTULINUM-TOXIN-A; SPINAL-CORD-INJURY; NITRIC-OXIDE; URINARY-BLADDER; NERVOUS-SYSTEM; RATS;
D O I
10.1016/j.neuint.2010.12.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ATP and NO are released from the urothelium in the bladder. Detrusor overactivity (DO) following spinal cord injury results in higher ATP and lower NO release from the bladder urothelium. Our aim was to study the relationship between ATP and NO release in (1) early diabetic bladders, an overactive bladder model; and (2) "diuretic" bladders, an underactive bladder model. To induce diabetes mellitus female rats received 65 mg/kg streptozocin (i.v.). To induce chronic diuresis rats were fed with 5% sucrose. At 28 days, in vivo open cystometry was performed. Bladder wash was collected to analyze the amount of ATP and NO released into the bladder lumen. For in vitro analysis of ATP and NO release, a Ussing chamber was utilized and hypoosmotic Krebs was perfused on the urothelial side of the chamber. ATP was analyzed with luminometry or HPLC-fluorometry while NO was measured with a Sievers NO-analyzer. In vivo ATP release was increased in diabetic bladders and unchanged in diuretic bladders. In vitro release from the urothelium followed the same pattern. NO release was unchanged both in vitro and in vivo in overactive bladders whereas it was enhanced in underactive bladders. We found that the ratio of ATP/NO, representing sensory transmission in the bladder, was high in overactive and low in underactive bladder dysfunction. In summary, ATP release has a positive correlation while NO release has a negative correlation with the bladder contraction frequency. The urinary ATP/NO ratio may be a clinically relevant biomarker to characterize the extent of bladder dysfunction. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:295 / 300
页数:6
相关论文
共 50 条
  • [21] Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia
    Kaplan, Steven A.
    Roehrborn, Claus G.
    Dmochowski, Roger
    Rovner, Eric S.
    Wang, Joseph T.
    Guan, Zhonghong
    UROLOGY, 2006, 68 (02) : 328 - 332
  • [22] GEMCITABINE ENHANCES RELEASE OF ATP BUT NOT ACETYLCHOLINE OR PGE2 FROM BLADDER UROTHELIAL CELLS
    Farr, Stefanie
    Chess-Williams, Russ
    McDermott, Catherine
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 131 - 131
  • [23] Botulinum toxin A inhibits mechanoreceptor-mediated urothelial release of ATP in conditions of bladder inflammation
    Vemulakonda, VM
    Smith, CP
    Kiss, S
    Khera, M
    Evans, JL
    Boone, TB
    Somogyi, GT
    JOURNAL OF UROLOGY, 2004, 171 (04): : 95 - 95
  • [24] RELATIONSHIP BETWEEN THE URINARY, UROTHELIAL AND VAGINAL MICROBIOME IN OVERACTIVE BLADDER
    Veit-Rubin, N.
    Mahboobani, K. S.
    Cartwright, R.
    Ford, A.
    Asfour, V
    Digesu, A.
    Fernando, R.
    Khullar, V
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 : S41 - S42
  • [25] UROTHELIAL DYSFUNCTION AND ALTERATIONS OF SENSORY PROTEIN EXPRESSIONS IN BLADDER MUCOSA IN PATIENTS WITH IDIOPATHIC DETRUSOR UNDERACTIVITY
    Jiang, Y.
    Liu, H.
    Kuo, H.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S186 - S188
  • [26] Coexisting overactive-underactive bladder and detrusor overactivity-underactivity in pelvic organ prolapse
    Frigerio, Matteo
    Barba, Marta
    Cola, Alice
    Spelzini, Federico
    Milani, Rodolfo
    Manodoro, Stefano
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2023, 160 (01) : 256 - 262
  • [27] CLINICAL EFFICACY OF SOLIFENACIN ON FEMALE SEXUAL DYSFUNCTION IN PATIENTS WITH OVERACTIVE BLADDER (SOS TRIAL; SOLIFENACIN ON OVERACTIVE BLADDER AND SEXUAL DYSFUNCTION)
    Oh, Cheol Young
    Kim, Tae Hyo
    Hwang, Ji Won
    Bang, Woo Jin
    Yoo, Changhee
    Lee, Young Goo
    Cho, Jin Seon
    JOURNAL OF UROLOGY, 2013, 189 (04): : E618 - E619
  • [28] Tolterodine extended-release for overactive bladder
    Chung, Doreen E.
    Te, Alexis E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (13) : 2181 - 2194
  • [29] Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury
    Smith, Christopher P.
    Gangitano, David A.
    Munoz, Alvaro
    Salas, Nilson A.
    Boone, Timothy B.
    Aoki, K. Roger
    Francis, Joseph
    Somogyi, George T.
    NEUROCHEMISTRY INTERNATIONAL, 2008, 52 (06) : 1068 - 1075
  • [30] Botulinum toxin type a normalizes alterations in urothelial ATP and no release caused by chronic spinal cord injury
    Smith, Christopher P.
    Gangitano, DavidA
    Munoz, Alvaro
    Salas, Nilson A.
    Boone, Timothy B.
    Aoki, K. R.
    Francis, Joseph
    Somogyi, George T.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 77 - 77